The best indicator for KKR & Co. (KKR)
We backtested 20 indicators across daily, weekly and hourly charts on real KKR & Co. (KKR) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
EMA 20/50 Cross
On the daily chart, this is the strongest risk-adjusted edge we found for KKR & Co. (KKR) over ~15.9 years — trailing buy-and-hold by 3.6% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | EMA 20/50 Cross ✓ | Daily | 15.5% | 0.72 | -40.2% | 48.4% | 31 | -3.6% |
| 2 | RSI Trend (>50) ✓ | Daily | 14.1% | 0.68 | -41.7% | 38.5% | 208 | -5.0% |
| 3 | Rate of Change ✓ | Weekly | 13.6% | 0.64 | -41.2% | 65.9% | 44 | -5.8% |
| 4 | RSI Trend (>50) ✓ | Weekly | 13.2% | 0.62 | -47.4% | 57.1% | 42 | -6.1% |
| 5 | Donchian Midline ✓ | Daily | 10.6% | 0.53 | -47.5% | 38.2% | 225 | -8.5% |
| 6 | Donchian Breakout ✓ | Weekly | 9.6% | 0.53 | -40.9% | 42.9% | 14 | -9.8% |
| 7 | Bollinger Breakout ✓ | Weekly | 7.7% | 0.5 | -28.4% | 50.0% | 14 | -11.6% |
| 8 | Bollinger Mean-Reversion ✓ | Daily | 7.7% | 0.46 | -38.3% | 75.7% | 70 | -11.4% |
| 9 | MACD ✓ | Weekly | 7.9% | 0.45 | -35.6% | 54.5% | 33 | -11.5% |
| 10 | ADX / DMI ✓ | Weekly | 7.3% | 0.45 | -51.6% | 39.1% | 23 | -12.1% |
| 11 | EMA-10 Trend ✓ | Weekly | 8.1% | 0.45 | -48.2% | 58.9% | 73 | -11.3% |
| 12 | ADX / DMI ✓ | Daily | 6.1% | 0.43 | -38.4% | 37.2% | 94 | -13.0% |
| 13 | Heikin-Ashi Trend | Daily | 7.6% | 0.42 | -57.3% | 47.6% | 794 | -11.5% |
| 14 | Donchian Midline ✓ | Weekly | 7.5% | 0.42 | -65.6% | 52.9% | 51 | -11.9% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For KKR & Co. (KKR), EMA 20/50 Cross on the daily timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.